Organoid cultures derived from patients with advanced prostate cancer. - Wikidata - wikimedia - TriplyDB

Organoid cultures derived from patients with advanced prostate cancer.

Organoid cultures derived from patients with advanced prostate cancer.

http://www.wikidata.org/entity/Q34545103

about

Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine When Prostate Cancer Circulates in the Bloodstream Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics Value of Organoids from Comparative Epithelia Models Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Notch signaling in prostate cancer: refining a therapeutic opportunity Precision medicine for cancer with next-generation functional diagnostics Stem cells in genetically-engineered mouse models of prostate cancer The many ways to make a luminal cell and a prostate cancer cell Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures Cortical dynamics during cell motility are regulated by CRL3(KLHL21) E3 ubiquitin ligase.Integrative clinical genomics of advanced prostate cancer.Drug Discovery via Human-Derived Stem Cell Organoids Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Recent advances in the biology of human circulating tumour cells and metastasis Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back Organoid development in cancer genome discovery Using circulating tumor cells to inform on prostate cancer biology and clinical utility N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.Short term ex-vivo expansion of circulating head and neck tumour cells.Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines A Versatile Microarray Platform for Capturing Rare Cells Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.Cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids Genome engineering of stem cell organoids for disease modeling.Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide.Organoid models of human and mouse ductal pancreatic cancer Role of non-coding sequence variants in cancer.Reprogramming of human cancer cells to pluripotency for models of cancer progression Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy Tissue-engineered models of human tumors for cancer research.Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade.Bioluminescence-mediated longitudinal monitoring of adipose-derived stem cells in a large mammal ex vivo organ culture A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon.Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening.Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

P2860

Q26741336-81B9B52D-419C-4E03-B161-69B9F081C817 Q26768470-7440D17D-8CEA-4B40-8B0D-C9F71CD23A66 Q26773613-F79B3302-6866-46D3-91E9-13686E398800 Q26775816-D5AEA9D1-58D8-4852-8637-126E71017DA6 Q26777310-3923873C-11E4-483D-8FC1-4ADCA10CBE96 Q26777624-9EE32F4D-BC90-46DF-889F-113416C6AF7A Q26780232-23C84DDC-ACE5-481A-A846-91B3C54AC3B3 Q26784057-6FD655E9-ED72-4D78-8C7F-2B59399588C0 Q26797386-4C7F1925-CE6E-49FD-B7E5-5B157DCD529B Q27324252-A66EC876-D4F7-43DB-86AB-A844C1001776 Q27325699-08DE9EAC-4026-40D5-A1B9-A85F16CF57CF Q27853170-E01EE804-E923-4379-85F0-74E569384DE3 Q28066424-67437ED5-BF63-41DC-A920-FC3C61A80EF4 Q28068665-6ECD56B8-1EC1-4F62-A62B-E601916ADFB8 Q28070120-B9F9695C-241F-479B-BCDB-81375A7E45C6 Q28070333-EA7DBFD7-0CAD-4788-9DD5-993CDA52ECAA Q28083032-C6E54B2B-F904-400B-997D-0F3DF473CCB4 Q28083261-2D86D09C-C987-4B79-9048-B3CC8CAE6C1E Q28771715-50C9920A-E99A-4B6C-BBF1-6C09BEA4E1EF Q30355079-DDA1958F-5EB2-4701-AF5A-960A71C32747 Q30361741-8F514B68-E1F5-4BC5-8D1F-6DAF081A3ABA Q30398758-DD1CCE1C-4643-4215-84B1-941F81FB2D2E Q30670232-5EE03C57-1DCF-4B2E-BC7B-D585E79A9B6E Q30985881-FB212B7D-916A-497E-BB53-18D8B792A9E9 Q33607429-E54510D8-FB12-4E74-8445-EEB2336824F6 Q33628093-69AA9DCF-DC48-41A3-AFE9-4290D8DCE809 Q33650423-95DD8244-C3A2-44FB-8F1B-971E1823032B Q34456438-CC1DC882-72D4-4094-B5E7-7D2DA736F3F8 Q34509633-78F821A3-DAC3-4289-A9A1-E8D5811160FA Q35204997-2239C095-D33C-472D-8169-7AF40C6759B0 Q35640863-2F7D0717-4640-4927-9413-5FC8EB110738 Q35752053-62680E09-39B4-41CD-B85A-318914B67CC4 Q35776963-30A05585-1634-4F65-98B3-381A518390A4 Q35784738-702D03F3-3A83-4269-9059-FDCF72E3A36D Q35861427-A7C3CF8A-6DE9-43AC-ACCA-FF633D1A3921 Q36001579-48265C50-A167-4A9D-A5A1-883BE5344CB2 Q36040159-A1090C9E-E064-4609-906A-860ACAD79E20 Q36106633-87D29F5D-7D0D-4622-9C79-BD466E0C61CD Q36192485-09CE0130-78E3-4487-8DD9-1A74778E6F41 Q36238283-1FEAB3FC-CC91-46CE-8E5E-049A42D45BB1

P2860

Organoid cultures derived from patients with advanced prostate cancer.

http://www.wikidata.org/entity/Q34545103

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Organoid cultures derived from patients with advanced prostate cancer.

@ast

Organoid cultures derived from patients with advanced prostate cancer.

@en

Organoid cultures derived from patients with advanced prostate cancer.

@nl

type

label

Organoid cultures derived from patients with advanced prostate cancer.

@ast

Organoid cultures derived from patients with advanced prostate cancer.

@en

Organoid cultures derived from patients with advanced prostate cancer.

@nl

prefLabel

Organoid cultures derived from patients with advanced prostate cancer.

@ast

Organoid cultures derived from patients with advanced prostate cancer.

@en

Organoid cultures derived from patients with advanced prostate cancer.

@nl

P1433

Q34545103-30C59D6D-4046-4BD7-AB4C-3007191A7CFE

P1476

Q34545103-DD353C67-D42A-4017-A038-A79B2BDA6DB0

P2093

Q34545103-0AE54065-AD1D-4A69-8209-9147AC2F7A03

Q34545103-0AF00C99-CC19-4713-82C0-212923F57C75

Q34545103-102A7DEA-DD2E-4748-9B31-C7511EAA5773

Q34545103-1C5D78FF-3086-4274-B2E0-973CC3751CF7

Q34545103-1F1FA3E5-D5B9-46D7-9112-9838B277F40C

Q34545103-2156B02E-8EB3-42FC-83CD-2EE3603F5AA8

Q34545103-286A1261-CC2D-4FF7-BC34-CF4443D1EF92

Q34545103-2F215BB3-7C85-4E63-AFE6-78BD1FA11EB6

Q34545103-2FE7472D-F1B7-4677-8064-891F0BECE5E9

Q34545103-30C51D22-D5C8-4211-BF97-6FE94BD12A37

P2860

Q34545103-00B38AB2-9D81-4A79-8E73-5E7AEA1D3453

Q34545103-21EB6AA0-910F-4117-96B0-E5DAC14204EA

Q34545103-2232E4AE-AE4F-4DBF-B6C0-E4CB0DCA37CE

Q34545103-277ECD9A-F2AF-4641-BF8E-3B558AAB0FF0

Q34545103-278770FC-2BB2-4006-BD86-2A7F07CF78CA

Q34545103-2CDAC78E-5296-41BC-B3E4-9C8D9099759A

Q34545103-32D862EC-99FA-4B62-ADFD-7B5EF9E332AE

Q34545103-50AAE263-F80B-4C4D-8469-43B8FDC7108B

Q34545103-58E21628-107A-4BBE-BC87-1BF54B74A4ED

Q34545103-595792DA-EA5D-4C7D-BA94-A0AFB1BF4101

P304

Q34545103-14EFD78B-F3D1-480D-9209-67DBBA2912F5

P31

Q34545103-BBADE8C8-4B44-4923-8549-36A54FB58164

P356

Q34545103-1CDA6F6F-5329-49BD-B5E2-CE87D4464E4F

P407

Q34545103-7358136D-9728-4A5A-B74E-43FAF5C92E30

P433

Q34545103-558615C1-3D9F-4BA5-9C28-CDDC60B826D6

P478

Q34545103-C87CDE92-EAAE-4DD8-B66A-4EF3722BA5CD

P50

Q34545103-13EAF1F7-A72B-477C-B05D-E7CCD9F9A469

Q34545103-4B3E936F-0911-422C-B736-DFD15BCC5372

Q34545103-7D43265C-FF63-44C6-BFFD-FE58EAE1768E

Q34545103-B57A939C-1469-423F-9BBE-EDD80553190E

P577

Q34545103-6BEEAD2B-13FE-4E2D-8949-11EAC24FA05F

P5875

Q34545103-7E3624C2-5B88-4754-BEE9-349BD7C0ADED

P698

Q34545103-EFB4D047-C6D1-4546-8E4B-AD55FC2C601F

P932

Q34545103-290458F8-11CC-4C54-9690-B0F531AD214E

P356

J.CELL.2014.08.016

P1433

P1476

Organoid cultures derived from patients with advanced prostate cancer.

@en

P2093

Andrea Sboner

http://www.w3.org/2001/XMLSchema#string

Anuradha Gopalan

http://www.w3.org/2001/XMLSchema#string

Brett Carver

http://www.w3.org/2001/XMLSchema#string

Catherine Dowling

http://www.w3.org/2001/XMLSchema#string

Charles L Sawyers

http://www.w3.org/2001/XMLSchema#string

Daniel C Danila

http://www.w3.org/2001/XMLSchema#string

Eva A Undvall

http://www.w3.org/2001/XMLSchema#string

Hans Clevers

http://www.w3.org/2001/XMLSchema#string

Himisha Beltran

http://www.w3.org/2001/XMLSchema#string

Howard I Scher

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

The role of SPINK1 in ETS rearrangement-negative prostate cancers

Integrated genomic analyses of ovarian carcinoma

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Overcoming mutation-based resistance to antiandrogens with rational drug design

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis

Fast and accurate long-read alignment with Burrows-Wheeler transform

P304

176-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2014.08.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

159

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Morris

Dana E Rathkopf

P577

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267737680

http://www.w3.org/2001/XMLSchema#string

P698

25201530

http://www.w3.org/2001/XMLSchema#string

P932

4237931

http://www.w3.org/2001/XMLSchema#string